WebMD to launch Medscape iPhone app

Share this article:
WebMD to launch Medscape iPhone app
WebMD to launch Medscape iPhone app

WebMD hopes to extend its professional network reach with the launch of a Medscape iPhone application. The app will become available during the last week of May, or in early June, according to a WebMD spokesperson.

The app will provide docs with a free mobile drug reference database and drug interaction checker, as well as Medscape's specialty-focused professional news. Medscape CME will be available as well, with mobile CME activities and credits automatically tracked in the Medscape CME tracker.

Regarding the potential for targeted marketing opportunities, WebMD's spokesperson said: “We are focused right now on putting quality applications onto mobile devices, and as we build a mobile user community, commercial opportunities will follow.”

XM radio station ReachMD launched a CME application for the iPhone last November, providing on-demand XM radio CME content and testing direct to the mobile device.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...